Adenosine and kidney function: potential implications in patients with heart failure.
about
Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statementAdenosine receptors and the kidneyCardiac purinergic signalling in health and diseaseInfluence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney.Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.Overview of emerging pharmacotherapy in chronic heart failure.Emerging therapies for heart failure: renal mechanisms and effects.Can we improve the treatment of congestion in heart failure?Can we prevent or treat renal dysfunction in acute heart failure?Novel therapeutic targets for the treatment of heart failure.Ultrafiltration therapy for cardiorenal syndrome: physiologic basis and contemporary options.Cardiorenal syndrome: pathophysiology and potential targets for clinical management.Pharmacological treatment of acute heart failure: current treatment and new targets.Cardiorenal syndrome: new developments in the understanding and pharmacologic management.Changes in renal function in congestive heart failure.Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.Renal neurohormonal regulation in heart failure decompensation.Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.Current Approach to Decongestive Therapy in Acute Heart Failure.Partial Adenosine A1 Agonist in Heart Failure.Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.Effect of infliximab against cisplatin-induced nephrotoxicity.Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy.Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure.
P2860
Q26786569-05F7DAF0-9A4A-4F59-A3B7-DA6FD5E35AA0Q28253255-11E88769-F3C2-42C7-856E-95E56B1BDABCQ33165093-51FE4144-086F-4B29-AC1C-27CCF2878FF8Q35432267-67B3AA7C-F2D7-4C6D-9B62-1A4349FE3C82Q35787419-3E01DB27-A2B7-4F13-8D8E-73C9B0909B1CQ36312662-A5BE1772-98D8-4B49-8AA0-AEFAFAC58432Q37030536-37831CDD-9CF8-4148-AF80-FF2980BF3D9DQ37552943-6009D28D-FAB1-481C-92BC-CAB0E71FD15BQ37783956-95F84890-C69F-4DE7-B6FC-8EC22A7FFEC1Q37845856-3CB04B31-F58C-416F-9886-51E79C44C643Q37873812-C88587D7-4957-41F6-BA40-1C6470FE2A44Q37893956-E95E3B2E-9A5A-48C9-8916-55DA6C6F93B7Q38055287-6CA45C59-6D3A-4B98-AB0B-B80CF5DD86AAQ38068097-8A65F542-DADD-4C07-B5A5-EB314246B972Q38122297-883D1BE7-D642-4E40-97E8-2FB63087F5D0Q38127668-7FA26544-DD79-4A81-B837-CC4CB10102A7Q38155422-BE41CA84-9FCF-4982-92C6-1CCA2C458343Q38173317-DFA2A7A9-B94D-4DEA-BC2D-B836F26E3007Q38219634-FBD88AAD-6795-40CE-9523-9EF489501F5EQ38307958-04D5BE4A-BED4-4D85-9A27-52DCC3FD3133Q38612606-BA40AE09-E560-4725-84EF-9221552BFFAFQ38988016-A32066B8-9975-4E8B-B966-EDAD4211C00DQ39269611-7FD83B6D-7A5C-4CBF-8778-F0688DB2007AQ43189109-13E1DEFA-7B65-4527-8294-9F593DC50B0EQ43238410-97490CA1-EF52-4F2C-A444-7E942A050291Q48732639-67C3A445-E1E3-4A6A-9AB4-3007044C7AADQ52847761-48B493A3-126B-49D1-A27D-02047535D031
P2860
Adenosine and kidney function: potential implications in patients with heart failure.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Adenosine and kidney function: potential implications in patients with heart failure.
@ast
Adenosine and kidney function: potential implications in patients with heart failure.
@en
type
label
Adenosine and kidney function: potential implications in patients with heart failure.
@ast
Adenosine and kidney function: potential implications in patients with heart failure.
@en
prefLabel
Adenosine and kidney function: potential implications in patients with heart failure.
@ast
Adenosine and kidney function: potential implications in patients with heart failure.
@en
P2093
P2860
P1476
Adenosine and kidney function: potential implications in patients with heart failure.
@en
P2093
Cindy Miracle
Scott Thomson
Volker Vallon
P2860
P304
P356
10.1016/J.EJHEART.2008.01.010
P577
2008-02-01T00:00:00Z